HCA Holdings Inc (HCA)

HCA (NYSE:Health Services) EQUITY
neg -0.76
Today's Range: 73.69 - 75.44 | HCA Avg Daily Volume: 2,410,400
Last Update: 08/26/16 - 4:00 PM EDT
Volume: 2,794,412
YTD Performance: 10.93%
Open: $74.96
Previous Close: $75.02
52 Week Range: $60.07 - $89.84
Oustanding Shares: 378,646,200
Market Cap: 28,027,391,724
6-Month Chart
TheStreet Ratings Grade for HCA
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 14 14 14
Moderate Buy 1 1 1 1
Hold 4 4 4 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.53 1.47 1.47 1.39
Latest Dividend: 2.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/13/12
Price Earnings Ratio: 12.78
Price Earnings Comparisons:
HCA Sector Avg. S&P 500
12.78 12.80 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-3.49% -9.73% 96.08%
Revenue 7.50 0.20 0.06
Net Income 13.60 0.30 0.10
EPS 20.00 0.40 0.12
Earnings for HCA:
Revenue 39.68B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $1.44 $1.78 $6.59 $7.02
Number of Analysts 12 11 13 12
High Estimate $1.51 $1.88 $6.70 $7.24
Low Estimate $1.37 $1.68 $6.45 $6.68
Prior Year $1.17 $1.69 $5.56 $6.59
Growth Rate (Year over Year) 22.72% 5.33% 18.57% 6.51%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Rising costs of benefits affects employees and employers.
Names that shareholders should watch are those where PE firms hold big stakes in their companies.
Jul 29, 2016 | 7:31 AM EDT
HCA was downgraded from Overweight to Neutral, JP Morgan said. $85 price target. Hospital industry margins appear to have peaked.
Latest 13F shows the hedge fund like Cowen, Intelsat and more.
The private-equity firm gave some great tips in its earnings call.
Candidates have decried rising drug and medical prices, but there are reasons to like these stocks.
Mar 14, 2016 | 7:27 AM EDT
HCA was upgraded from Neutral to Overweight, JP Morgan said. $85 price target. Labor cost trends do not appear to be as bad as expected...
Two significant, but subtle forces may threaten the group in the next 12 months.
Jan 06, 2016 | 7:06 AM EST
HCA was downgraded to Market Perform, Leerink Partners said. $74 price target. Fundamentals are week, given ACA headwinds. 

Columnist Conversations

FIBOCALL: The SPX-cash after Ms. Yellen speaks. The "markets" actually moved today after the FED spoke. Fir...
Finally going to hear the latest views of Yellen today and the market and investor have largely been on hold b...
The BLS revised second quarter 20-16 GDP lower by 0.1% to 1.1%. This should provide adequate cover for the Fe...
We have followed all areas of the Healthcare industry for decades. And while there are likely many causes for ...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.